Biotech | August 16, 2022
PharmaCyte Biotech reaches cooperation agreement with Iroquois Capital
Company appoints five new independent directors to reconstituted board
Company appoints five new independent directors to reconstituted board
The hospital will use the bus to reach out to people with eye ailments through their various eye camps, diagnosing and treating them wherever possible.
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment of US $75 million (Rs. 555 crores) by Abu Dhabi based ADQ, one of the region’s largest holding companies.
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
It promises fewer injections for vision loss patients
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
Subscribe To Our Newsletter & Stay Updated
